TENAX THERAPEUTICS, INC. (TENX)
Every FINRA and SEC series the site collects for TENAX THERAPEUTICS, INC.: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq.
9.3M
Short interest
settlement 2026-08-31
1.1
Days to cover
+69.5% vs prior
61.6%
Short share of volume
2026-09-17
163
Fails to deliver
settlement 2026-08-27
Wed 11 Nov
Next earnings
estimated; last year 2025-11-12
4 people
Insiders buying, 30 days
$4.9M combined, latest 2026-09-16
$4.9M
Insider flow, 90 days
11 buys, 0 sells
As of 2026-09-17.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 31 August 2026, short interest in TENX is 9,276,905 shares, up 6,720,427 shares over the last month. Over the last 48 readings it ranged from 21,026 shares (15 October 2024) to 9,276,905 shares (31 August 2026). The latest reading sits at the top of that range. At the reported average volume of 8.3M shares a day that is 1.1 days to cover.
Embed this chartkeeps the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/tenx" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-31 | 9,276,905 | +69.5% | 8,254,803 | 1.12 |
| 2026-08-14 | 5,473,983 | +114.1% | 13,363,573 | 1.00 |
| 2026-07-31 | 2,556,478 | +24.9% | 1,374,109 | 1.86 |
| 2026-07-15 | 2,046,537 | +14.5% | 1,493,631 | 1.37 |
| 2026-06-30 | 1,787,937 | +132.9% | 1,507,495 | 1.19 |
| 2026-06-15 | 767,532 | -3.1% | 941,212 | 1.00 |
| 2026-05-29 | 792,041 | +2.1% | 443,319 | 1.79 |
| 2026-05-15 | 775,851 | +6.2% | 693,464 | 1.12 |
| 2026-04-30 | 730,696 | +275.8% | 639,900 | 1.14 |
| 2026-04-15 | 194,456 | +12.6% | 524,982 | 1.00 |
| 2026-03-31 | 172,743 | +13.0% | 371,622 | 1.00 |
| 2026-03-13 | 152,873 | +27.0% | 491,005 | 1.00 |
| 2026-02-27 | 120,380 | -3.1% | 207,786 | 1.00 |
| 2026-02-13 | 124,196 | +3.7% | 157,286 | 1.00 |
| 2026-01-30 | 119,746 | -39.0% | 255,620 | 1.00 |
| 2026-01-15 | 196,421 | +111.0% | 445,743 | 1.00 |
| 2025-12-31 | 93,087 | -82.5% | 206,055 | 1.00 |
| 2025-12-15 | 531,101 | -11.6% | 186,780 | 2.84 |
| 2025-11-28 | 600,469 | -20.8% | 133,369 | 4.50 |
| 2025-11-14 | 758,227 | -0.5% | 39,105 | 19.39 |
| 2025-10-31 | 762,345 | +1.1% | 86,522 | 8.81 |
| 2025-10-15 | 754,325 | +36.2% | 106,153 | 7.11 |
| 2025-09-30 | 553,719 | +101.1% | 163,085 | 3.40 |
| 2025-09-15 | 275,372 | -7.5% | 50,043 | 5.50 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 17 September 2026, the short share of TENX volume is 61.6%, up 12.1 points over the last five sessions. Over the last 52 readings it ranged from 21.5% (13 August 2026) to 72.5% (18 August 2026). The latest reading is 16.7 points above the 30-session average of 44.9%, on 2.0M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-17 | 1.3M | 2.0M | 61.6% | 6,059 |
| 2026-09-16 | 380K | 1.0M | 37.4% | 4,666 |
| 2026-09-15 | 349K | 780K | 44.8% | 3,130 |
| 2026-09-14 | 554K | 1.1M | 50.5% | 11,179 |
| 2026-09-11 | 579K | 1.4M | 42.1% | 3,138 |
| 2026-09-10 | 1.1M | 2.2M | 49.5% | 19,294 |
| 2026-09-09 | 2.2M | 4.9M | 45.1% | 22,681 |
| 2026-09-08 | 1.2M | 3.6M | 34.4% | 61,697 |
| 2026-09-04 | 773K | 2.5M | 30.6% | 521 |
| 2026-09-03 | 2.3M | 3.5M | 65.4% | 2,773 |
| 2026-09-02 | 591K | 1.7M | 34.0% | 25,266 |
| 2026-09-01 | 681K | 2.1M | 32.1% | 183,283 |
| 2026-08-31 | 7.3M | 11.3M | 65.0% | 937,641 |
| 2026-08-28 | 725K | 1.5M | 49.5% | 4,882 |
| 2026-08-27 | 716K | 1.4M | 51.9% | 2,457 |
| 2026-08-26 | 1.4M | 2.7M | 53.7% | 7,407 |
| 2026-08-25 | 2.9M | 7.9M | 36.5% | 20,334 |
| 2026-08-24 | 936K | 2.4M | 39.5% | 28,023 |
| 2026-08-21 | 1.6M | 2.4M | 67.9% | 250 |
| 2026-08-20 | 1.7M | 2.5M | 70.6% | 25,647 |
| 2026-08-19 | 1.6M | 4.1M | 38.9% | 24,432 |
| 2026-08-18 | 4.3M | 5.9M | 72.5% | 33,632 |
| 2026-08-17 | 2.1M | 5.7M | 37.1% | 103 |
| 2026-08-14 | 675K | 2.5M | 26.6% | 3,665 |
| 2026-08-13 | 1.2M | 5.4M | 21.5% | 6,311 |
| 2026-08-12 | 1.8M | 7.3M | 24.6% | 28,847 |
| 2026-08-11 | 6.3M | 20.4M | 30.8% | 1,698,528 |
| 2026-08-10 | 24.2M | 38.2M | 63.4% | 3,487,030 |
| 2026-08-07 | 357K | 1.0M | 35.3% | 0 |
| 2026-08-06 | 166K | 498K | 33.4% | 243 |
Fails to deliver
SEC, by settlement date. JSONAs of 27 August 2026, the fails-to-deliver balance in TENX is 163 shares, down 4,233 shares over the last settlement date. Over the last 52 readings it ranged from 13 shares (26 June 2026) to 1,027,432 shares (19 August 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-27 | 163 | $2.12 | $346 |
| 2026-08-26 | 4,396 | $2.32 | $10K |
| 2026-08-25 | 45 | $1.85 | $83 |
| 2026-08-24 | 2,716 | $1.75 | $5K |
| 2026-08-21 | 3,785 | $1.78 | $7K |
| 2026-08-20 | 16,858 | $1.90 | $32K |
| 2026-08-19 | 1,027,432 | $1.70 | $1.7M |
| 2026-08-18 | 4,636 | $1.71 | $8K |
| 2026-08-14 | 911 | $1.83 | $2K |
| 2026-08-12 | 5,766 | $1.62 | $9K |
| 2026-08-11 | 825,289 | $1.38 | $1.1M |
| 2026-08-05 | 20 | $13.82 | $276 |
| 2026-08-04 | 3,521 | $14.33 | $50K |
| 2026-07-17 | 810 | $15.08 | $12K |
| 2026-07-14 | 131 | $15.98 | $2K |
| 2026-06-29 | 14,189 | $13.44 | $191K |
| 2026-06-26 | 13 | $12.89 | $168 |
| 2026-06-15 | 237,037 | $11.48 | $2.7M |
| 2026-06-10 | 14,000 | $10.73 | $150K |
| 2026-06-09 | 50,361 | $10.54 | $531K |
| 2026-06-08 | 63,205 | $10.73 | $678K |
| 2026-06-02 | 28,879 | $11.97 | $346K |
| 2026-04-10 | 40,470 | $14.96 | $605K |
| 2026-04-07 | 1,200 | $14.88 | $18K |
| 2026-03-04 | 6,697 | $11.42 | $76K |
| 2026-03-02 | 517 | $12.00 | $6K |
| 2026-02-20 | 934 | $12.43 | $12K |
| 2026-02-18 | 1,219 | $12.48 | $15K |
| 2026-02-10 | 5,657 | $13.00 | $74K |
| 2026-02-09 | 74,000 | $12.73 | $942K |
Insider trades
SEC Form 4, newest first, 50 of 66 shown. JSONInsiders at TENX reported 11 open-market buys worth $4.9M in the last 90 days and no open-market sells. Clustered voluntary buying is historically the stronger insider signal because insiders buy for one reason. Latest filing: Doogan Declan on 2026-09-16.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-16 | Doogan Declan | n/a | Buy | 53K | $1.92 | $102K | 55K |
| 2026-09-15 | Giordano Christopher Thomas | CEO | Buy | 5K | $1.82 | $9K | 22K |
| 2026-09-11 | STAAB THOMAS R II | Chief Financial Officer | Buy | 6K | $1.94 | $11K | 16K |
| 2026-09-11 | Giordano Christopher Thomas | CEO | Buy | 6K | $1.88 | $11K | 17K |
| 2026-09-03 | ADAR1 Capital Management, LLC | n/a | Buy | 900K | $1.78 | $1.6M | 6.5M |
| 2026-09-02 | ADAR1 Capital Management, LLC | n/a | Buy | 188K | $1.80 | $338K | 5.6M |
| 2026-09-01 | ADAR1 Capital Management, LLC | n/a | Buy | 179K | $1.80 | $322K | 5.4M |
| 2026-08-31 | ADAR1 Capital Management, LLC | n/a | Buy | 404K | $1.79 | $723K | 5.3M |
| 2026-08-24 | ADAR1 Capital Management, LLC | n/a | Buy | 107K | $1.75 | $188K | 4.9M |
| 2026-08-21 | ADAR1 Capital Management, LLC | n/a | Buy | 716K | $1.77 | $1.3M | 4.7M |
| 2026-08-20 | ADAR1 Capital Management, LLC | n/a | Buy | 202K | $1.78 | $360K | 4.0M |
| 2026-05-11 | STAAB THOMAS R II | Chief Financial Officer | Grant | 10K | $0.00 | $0 | 10K |
| 2025-12-09 | Rich Stuart | Chief Medical Officer | Buy | 3K | $10.22 | $26K | 5K |
| 2025-12-08 | Rich Stuart | Chief Medical Officer | Buy | 3K | $10.10 | $25K | 5K |
| 2025-12-04 | Rich Stuart | Chief Medical Officer | Buy | 3K | $9.20 | $23K | 3K |
| 2025-12-03 | Rich Stuart | Chief Medical Officer | Buy | 2K | $9.08 | $14K | 3K |
| 2025-12-02 | Rich Stuart | Chief Medical Officer | Buy | 1K | $9.01 | $9K | 1K |
| 2025-11-20 | Giordano Christopher Thomas | CEO | Buy | 538 | $7.59 | $4K | 3K |
| 2025-11-19 | Giordano Christopher Thomas | CEO | Buy | 455 | $7.51 | $3K | 2K |
| 2025-11-18 | Almenoff June Sherie | Director | Buy | 2K | $7.52 | $14K | 2K |
| 2025-11-18 | Almenoff June Sherie | n/a | Buy | 2K | $7.52 | $14K | 2K |
| 2025-11-18 | Giordano Christopher Thomas | CEO | Buy | 2K | $7.75 | $13K | 2K |
| 2025-11-17 | Almenoff June Sherie | Director | Buy | 93 | $7.15 | $665 | 93 |
| 2025-11-17 | MCGAULEY THOMAS | Interim CFO | Buy | 5K | $7.23 | $36K | 5K |
| 2025-11-17 | MCGAULEY THOMAS | Interim CFO | Buy | 1K | $7.35 | $7K | 1K |
| 2025-11-17 | MCGAULEY THOMAS | Interim CFO | Buy | 2K | $7.34 | $15K | 2K |
| 2025-11-17 | Almenoff June Sherie | n/a | Buy | 93 | $7.15 | $665 | 93 |
| 2024-08-08 | Davidson Michael H. | Director | Buy | 3K | n/a | n/a | 3K |
| 2024-08-08 | PROEHL GERALD T | Director | Buy | 2K | n/a | n/a | 2K |
| 2022-09-21 | Rich Stuart | Chief Medical Officer | Gift | 1.9M | $0.00 | $0 | 424K |
| 2022-08-11 | Doogan Declan | Director,TenPercentOwner | Gift | 568K | $0.00 | $0 | 3.6M |
| 2021-11-29 | Rich Stuart | Chief Medical Officer | Gift | 1.9M | $0.00 | $0 | 1.9M |
| 2021-10-12 | Rich Stuart | Chief Medical Officer | Gift | 1.9M | $0.00 | $0 | 1.9M |
| 2021-06-30 | Doogan Declan | Director,TenPercentOwner | Gift | 568K | $0.00 | $0 | 2.5M |
| 2021-06-11 | Doogan Declan | Director,TenPercentOwner | Option exercise | 3.1M | n/a | n/a | 3.6M |
| 2021-06-11 | Davidson Michael H. | Director | Grant | 512K | n/a | n/a | 607K |
| 2021-06-11 | Rich Stuart | Chief Medical Officer | Option exercise | 3.6M | n/a | n/a | 4.2M |
| 2021-01-15 | Rich Stuart | Chief Medical Officer | Grant | 4K | n/a | n/a | 4K |
| 2021-01-15 | Rich Stuart | Chief Medical Officer | Grant | 663K | n/a | n/a | 663K |
| 2020-09-08 | Armistice Capital Master Fund Ltd. | Director,TenPercentOwner | Buy | 9K | $1.46 | $12K | 2.0M |
| 2020-09-08 | Armistice Capital Master Fund Ltd. | Director,TenPercentOwner | Buy | 0 | $0.00 | $0 | 2.0M |
| 2020-09-04 | Armistice Capital Master Fund Ltd. | Director,TenPercentOwner | Buy | 0 | $0.00 | $0 | 2.0M |
| 2020-09-04 | Armistice Capital Master Fund Ltd. | Director,TenPercentOwner | Buy | 23K | $1.41 | $33K | 2.0M |
| 2020-09-03 | ARMISTICE CAPITAL, LLC | Director,TenPercentOwner | Buy | 0 | $0.00 | $0 | 2.0M |
| 2020-09-03 | ARMISTICE CAPITAL, LLC | Director,TenPercentOwner | Buy | 36K | $1.39 | $50K | 2.0M |
| 2020-09-02 | ARMISTICE CAPITAL, LLC | Director,TenPercentOwner | Buy | 20K | $1.47 | $29K | 2.0M |
| 2020-09-02 | ARMISTICE CAPITAL, LLC | Director,TenPercentOwner | Buy | 0 | $0.00 | $0 | 2.0M |
| 2020-09-01 | ARMISTICE CAPITAL, LLC | Director,TenPercentOwner | Buy | 0 | $0.00 | $0 | 1.9M |
| 2020-09-01 | ARMISTICE CAPITAL, LLC | Director,TenPercentOwner | Buy | 30K | $1.46 | $44K | 1.9M |
| 2020-08-31 | ARMISTICE CAPITAL, LLC | Director,TenPercentOwner | Buy | 20K | $1.45 | $29K | 1.9M |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Large holders (13D and 13G)
One row per reporting person, newest filing first. JSON43 holders above 5% have filed on TENX, 1 on Schedule 13D (active intent). The largest reported stake is ADAR1 Capital Management, LLC at 14.0% of the class (5,257,389 shares), filed 2026-09-08 for an event on 2026-08-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-09-11 | 13G/Ano. 1 | ING Groep N.V.parent holding company | 0 | 0.0% | 2026-09-03 |
| 2026-09-11 | 13G/Ano. 1 | ING Capital Markets LLCother entity | 0 | 0.0% | 2026-09-03 |
| 2026-09-08 | 13G | ADAR1 Capital Management, LLCinvestment adviser, other entity | 5.3M | 14.0% | 2026-08-31 |
| 2026-09-08 | 13G | Daniel Schneebergerparent holding company, individual | 5.3M | 14.0% | 2026-08-31 |
| 2026-09-08 | 13G/Ano. 1 | FMR LLCparent holding company | 515K | 1.4% | 2026-08-31 |
| 2026-09-08 | 13G/Ano. 1 | Abigail P. Johnsonindividual | 515K | 1.4% | 2026-08-31 |
| 2026-08-27 | 13G | ING Capital Markets LLCother entity | 2.6M | 7.0% | 2026-08-19 |
| 2026-08-27 | 13G | ING Groep N.V.parent holding company | 2.6M | 7.0% | 2026-08-19 |
| 2026-08-27 | 13G | Sphera Funds Management Ltd.corporation | 2.0M | 5.3% | 2026-08-17 |
| 2026-08-27 | 13G | Sphera Global Healthcare GP Ltd.corporation | 2.0M | 5.3% | 2026-08-17 |
| 2026-08-27 | 13G | Sphera Global Healthcare Management LPpartnership | 2.0M | 5.3% | 2026-08-17 |
| 2026-08-18 | 13G | Millennium Management LLCother entity | 2.2M | 5.8% | 2026-08-13 |
| 2026-08-18 | 13G | Millennium Group Management LLCother entity | 2.2M | 5.8% | 2026-08-13 |
| 2026-08-18 | 13G | Israel A. Englanderindividual | 2.2M | 5.8% | 2026-08-13 |
| 2026-08-14 | 13G/Ano. 3 | LAMPERT MARK Nindividual | 3.1M | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | BVF INC/ILcorporation | 3.1M | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | BVF PARTNERS L P/ILinvestment adviser, partnership | 3.1M | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | BVF GP HOLDINGS LLCother entity | 3.1M | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | RTW Investments, LPinvestment adviser, partnership | 2.9M | 9.9% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | Roderick Wongparent holding company, individual | 2.9M | 9.9% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | BVF I GP LLCother entity | 3.0M | 9.5% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | BIOTECHNOLOGY VALUE FUND L Ppartnership | 3.0M | 9.5% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Vivo Opportunity, LLCother entity | 3.5M | 9.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Vivo Opportunity Fund Holdings, L.P.partnership | 3.5M | 9.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 6 | Bong Y. Kohindividual | 1.6M | 4.7% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 6 | Venrock Healthcare Capital Partners III, L.P.partnership | 1.6M | 4.7% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 6 | VHCP Co-Investment Holdings III, LLCother entity | 1.6M | 4.7% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 6 | Venrock Healthcare Capital Partners EG, L.P.partnership | 1.6M | 4.7% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 6 | VHCP Management III, LLCother entity | 1.6M | 4.7% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 6 | VHCP Management EG, LLCother entity | 1.6M | 4.7% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 6 | Nimish Shahindividual | 1.6M | 4.7% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | Joseph Edelmanindividual | 1.7M | 4.5% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | Perceptive Life Sciences Master Fund, Ltd.corporation | 1.7M | 4.5% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | Perceptive Advisors LLCinvestment adviser | 1.7M | 4.5% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | Ikarian Capital, LLCinvestment adviser | 1.1M | 2.9% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | Neil Shahrestaniindividual, parent holding company | 1.1M | 2.9% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | BIOTECHNOLOGY VALUE FUND II LPpartnership | 142K | 0.5% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | BVF II GP LLCother entity | 142K | 0.5% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | BVF Partners OS Ltd.corporation | 7 | 0.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | Biotechnology Value Trading Fund OS LPpartnership | 7 | 0.0% | 2026-06-30 |
| 2026-08-12 | 13G/Ano. 1 | Adage Capital Management, L.P.investment adviser, partnership | 1.9M | 6.8% | 2026-06-30 |
| 2026-08-12 | 13G/Ano. 1 | Robert Atchinsonparent holding company, individual | 1.9M | 6.8% | 2026-06-30 |
| 2026-08-12 | 13G/Ano. 1 | Phillip Grossparent holding company, individual | 1.9M | 6.8% | 2026-06-30 |
| 2026-07-31 | 13D/Ano. 1 | Christopher Thomas Giordanoindividual | 1.7M | 4.3% | 2026-07-31 |
| 2026-07-30 | 13G | BlackRock, Inc.parent holding company | 1.7M | 6.4% | 2026-06-30 |
| 2026-07-17 | 13G/Ano. 1 | Millennium Management LLCother entity | 876K | 3.3% | 2026-06-30 |
| 2026-07-17 | 13G/Ano. 1 | Millennium Group Management LLCother entity | 876K | 3.3% | 2026-06-30 |
| 2026-07-17 | 13G/Ano. 1 | Israel A. Englanderindividual | 876K | 3.3% | 2026-06-30 |
| 2026-07-08 | 13G | Abigail P. Johnsonindividual | 3.9M | 14.9% | 2026-06-30 |
| 2026-07-08 | 13G | FMR LLCparent holding company | 3.9M | 14.9% | 2026-06-30 |
13F holders
Tracked managers holding TENX at their latest 13F. JSON5 of the 30 tracked managers held TENX at their latest 13F, $41.4M in total at quarter-end prices. Citadel Advisors is the largest at $13.0M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 0 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 895K | $13.0M | 0.00% | +743K |
| Millennium Management | 2026-06-30 | 876K | $12.7M | 0.00% | new or n/a |
| Point72 Asset Management | 2026-06-30 | 557K | $8.1M | 0.01% | +23K |
| Two Sigma Investments | 2026-06-30 | 353K | $5.1M | 0.00% | +285K |
| Renaissance Technologies | 2026-06-30 | 164K | $2.4M | 0.00% | +11K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
TENAX THERAPEUTICS, INC. in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows TENAX THERAPEUTICS, INC. (TENX), SEC CIK 34956, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-31.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-17.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-27.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-09-11.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K Item 2.02 (full-text search)EDGAR full-text search read twice a day; the estimate is last year's date plus 52 weeks. Latest 2026-07-31.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-09-16.JSON and CSV
- Company record
- EDGAR filing index for CIK 34956Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 18 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other company pages
- TEAMAtlassian Corp
- CVNACARVANA CO.
- CRMSalesforce, Inc.
- METAMeta Platforms, Inc.
- UTHRUNITED THERAPEUTICS Corp
- CRWVCoreWeave, Inc.
- RCGRENN Fund, Inc.
- ANETArista Networks, Inc.
- DDOGDatadog, Inc.
- NETCloudflare, Inc.
- DELLDell Technologies Inc.
- GOOGAlphabet Inc.
- CRWDCrowdStrike Holdings, Inc.
- TPLTexas Pacific Land Corp
- MRNAModerna, Inc.
- COINCoinbase Global, Inc.
- NOWServiceNow, Inc.
- MORNMorningstar, Inc.
- CPIXCUMBERLAND PHARMACEUTICALS INC
- DASHDoorDash, Inc.
- ZMZoom Communications, Inc.
- TDGTransDigm Group INC
- UBERUber Technologies, Inc
- PCTYPaylocity Holding Corp
Datasets
Frequently Asked Questions
How much of TENX is sold short?
What is TENX's daily short volume?
Does TENX have fails to deliver?
Are TENX insiders buying or selling?
Who owns more than 5% of TENX?
Which funds hold TENX?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.